Furthermore, RPL11 exhibits sustained upregulation in multiple non-healing wound models, including those driven by aging (98-week-old mice), diabetes (db/db mice), and inflammation (LPS-induced wounds) (14). Here, RPL11 is linked to diabetes mellitus.